GSA Capital Partners’s Galectin Therapeutics GALT Stock Holding History

GSA Capital Partners’s Portfolio GALT Stock Details GALT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$369K	Buy
2025 Q2	–	Sell
2025 Q1	$81K	Buy
2024 Q4	$28K	Buy
2019 Q2	–	Sell
2019 Q1	$291K	Buy